{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:04:53Z","timestamp":1792159493317,"version":"4.4.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009543","name":"Pontificia Universidad Javeriana","doi-asserted-by":"publisher","award":["20567"],"award-info":[{"award-number":["20567"]}],"id":[{"id":"10.13039\/501100009543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009543","name":"Pontificia Universidad Javeriana","doi-asserted-by":"publisher","award":["ID 5170"],"award-info":[{"award-number":["ID 5170"]}],"id":[{"id":"10.13039\/501100009543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009543","name":"Pontificia Universidad Javeriana","doi-asserted-by":"publisher","award":["120356933205"],"award-info":[{"award-number":["120356933205"]}],"id":[{"id":"10.13039\/501100009543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009543","name":"Pontificia Universidad Javeriana","doi-asserted-by":"publisher","award":["120356933427"],"award-info":[{"award-number":["120356933427"]}],"id":[{"id":"10.13039\/501100009543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009543","name":"Pontificia Universidad Javeriana","doi-asserted-by":"publisher","award":["20646"],"award-info":[{"award-number":["20646"]}],"id":[{"id":"10.13039\/501100009543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022965","name":"Colombia Ministerio de Ciencia Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022965","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e32555","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T06:02:00Z","timestamp":1718085720000},"page":"e32555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in a glyco-engineered Escherichia coli strain"],"prefix":"10.1016","volume":"10","author":[{"given":"Luisa N.","family":"Pimentel-Vera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rodr\u00edguez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J.","family":"Espejo-Mojica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aura Mar\u00eda","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7251-5298","authenticated-orcid":false,"given":"Luis H.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thapakorn","family":"Jaroentomeechai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3226-1566","authenticated-orcid":false,"given":"Matthew P.","family":"DeLisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar F.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6484-1173","authenticated-orcid":false,"given":"Carlos J.","family":"Alm\u00e9ciga-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.heliyon.2024.e32555_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041517","article-title":"Mucopolysaccharidosis IVA: diagnosis, treatment, and management","volume":"21","author":"Sawamoto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e32555_bib2","series-title":"Mucopolysaccharidoses Update (2 Volume Set)","first-page":"235","article-title":"Mucopolysaccharidosis type IVA: clinical features, biochemistry, diagnosis, genetics, and treatment","author":"Sawamoto","year":"2018"},{"issue":"24","key":"10.1016\/j.heliyon.2024.e32555_bib3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.21037\/atm.2018.11.39","article-title":"Lysosomal storage disease overview","volume":"6","author":"Sun","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e32555_bib4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40265-019-01147-4","article-title":"Therapeutic options for mucopolysaccharidoses: current and emerging treatments","volume":"79","author":"Sawamoto","year":"2019","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32555_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","article-title":"Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study","volume":"37","author":"Hendriksz","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e32555_bib6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/21678707.2016.1214572","article-title":"Current therapies for Morquio A syndrome and their clinical outcomes","volume":"4","author":"Sawamoto","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32555_bib7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40265-014-0210-z","article-title":"Elosulfase alfa: first global approval","volume":"74","author":"Sanford","year":"2014","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e32555_bib8","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/21678707.2015.1086640","article-title":"Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations","volume":"3","author":"Tomatsu","year":"2015","journal-title":"Expert Opin. Orphan Drugs"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e32555_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/21678707.2017.1366900","article-title":"Enzyme replacement therapy with elosulfase alfa for mucopolysaccharidosis IVA (Morquio A syndrome): milestones and challenges","volume":"5","author":"Puckett","year":"2017","journal-title":"Expert Opin Orphan Drugs"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e32555_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymgme.2015.06.001","article-title":"Human recombinant lysosomal enzymes produced in microorganisms","volume":"116","author":"Espejo-Mojica","year":"2015","journal-title":"Mol. Genet. Metabol."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e32555_bib11","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/hmg\/10.16.1639","article-title":"Enzyme therapy for lysosomal acid lipase deficiency in the mouse","volume":"10","author":"Du","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32555_bib12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1086\/498652","article-title":"The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy","volume":"77","author":"Du","year":"2005","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32555_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/bab.1660","article-title":"Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris","volume":"65","author":"Pimentel","year":"2018","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.heliyon.2024.e32555_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/srep29329","article-title":"Recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in the methylotrophic yeast Pichia pastoris","volume":"6","author":"Rodriguez-Lopez","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32555_bib15","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.xphs.2019.03.034","article-title":"Characterization of human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Pichia pastoris as potential enzyme for mucopolysaccharidosis IVA treatment","volume":"108","author":"Rodriguez-Lopez","year":"2019","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2024.e32555_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.11144\/Javeriana.SC21-3.corh","article-title":"Characterization of recombinant human lysosomal beta-hexosaminidases produced in the methylotrophic yeast Pichia pastoris","volume":"21","author":"Espejo-Mojica","year":"2016","journal-title":"Univ. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32555_bib17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ajmg.c.31849","article-title":"Human recombinant lysosomal beta-Hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay-Sachs fibroblasts","volume":"184","author":"Espejo-Mojica","year":"2020","journal-title":"Am. J. Med. Genet. Part C, Seminars in medical genetics"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32555_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2217\/fmb.14.104","article-title":"Engineering yeast for producing human glycoproteins: where are we now?","volume":"10","author":"Laukens","year":"2015","journal-title":"Future Microbiol."},{"key":"10.1016\/j.heliyon.2024.e32555_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12934-016-0437-3","article-title":"Recombinant pharmaceuticals from microbial cells: a 2015 update","volume":"15","author":"Sanchez-Garcia","year":"2016","journal-title":"Microb. Cell Factories"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32555_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00203-024-03871-2","article-title":"Essential factors, advanced strategies, challenges, and approaches involved for efficient expression of recombinant proteins in Escherichia coli","volume":"206","author":"Eskandari","year":"2024","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e32555_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2024.106463","article-title":"Escherichia coli as a versatile cell factory: advances and challenges in recombinant protein production","volume":"219","author":"Incir","year":"2024","journal-title":"Protein Expr. Purif."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32555_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tibtech.2013.03.003","article-title":"Expanding the glycoengineering toolbox: the rise of bacterial N-linked protein glycosylation","volume":"31","author":"Baker","year":"2013","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e32555_bib23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.copbio.2015.08.012","article-title":"Manipulating the glycosylation pathway in bacterial and lower eukaryotes for production of therapeutic proteins","volume":"36","author":"Anyaogu","year":"2015","journal-title":"Curr. Opin. Biotechnol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e32555_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrmicro2383","article-title":"Protein glycosylation in bacteria: sweeter than ever","volume":"8","author":"Nothaft","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32555_bib25","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1046\/j.1365-2958.1999.01415.x","article-title":"Evidence for a system of general protein glycosylation in Campylobacter jejuni","volume":"32","author":"Szymanski","year":"1999","journal-title":"Mol. Microbiol."},{"issue":"5802","key":"10.1016\/j.heliyon.2024.e32555_bib26","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1126\/science.1134351","article-title":"N-linked glycosylation of folded proteins by the bacterial oligosaccharyltransferase","volume":"314","author":"Kowarik","year":"2006","journal-title":"Science"},{"issue":"7351","key":"10.1016\/j.heliyon.2024.e32555_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature10151","article-title":"X-ray structure of a bacterial oligosaccharyltransferase","volume":"474","author":"Lizak","year":"2011","journal-title":"Nature"},{"issue":"5599","key":"10.1016\/j.heliyon.2024.e32555_bib28","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1126\/science.298.5599.1790","article-title":"N-linked glycosylation in Campylobacter jejuni and its functional transfer into E-coli","volume":"298","author":"Wacker","year":"2002","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32555_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nchembio.921","article-title":"An engineered eukaryotic protein glycosylation pathway in Escherichia coli","volume":"8","author":"Valderrama-Rincon","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32555_bib30","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1073\/pnas.0500044102","article-title":"Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli","volume":"102","author":"Feldman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e32555_bib31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ymben.2018.04.014","article-title":"A flow cytometric approach to engineering Escherichia coli for improved eukaryotic protein glycosylation","volume":"47","author":"Glasscock","year":"2018","journal-title":"Metab. Eng."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e32555_bib32","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s10295-010-0766-x","article-title":"Enzyme replacement therapy for Morquio A: an active recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Escherichia coli BL21","volume":"37","author":"Rodriguez","year":"2010","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e32555_bib33","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.procbio.2012.07.028","article-title":"Characterization of a recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in E. coli for enzyme replacement therapy of Morquio A disease","volume":"47","author":"Mosquera","year":"2012","journal-title":"Process Biochem."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32555_bib34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4014\/jmb.1211.11044","article-title":"Effect of culture conditions and signal peptide on production of human recombinant N-acetylgalactosamine-6-sulfate sulfatase in Escherichia coli BL21","volume":"23","author":"Hernandez","year":"2013","journal-title":"J. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32555_bib35","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1038\/s41598-017-06367-w","article-title":"Improvement in the production of the human recombinant enzyme N-acetylgalactosamine-6-sulfatase (rhGALNS) in Escherichia coli using synthetic biology approaches","volume":"7","author":"Reyes","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32555_bib36","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.procbio.2012.07.028","article-title":"Characterization of a recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in E. coli for enzyme replacement therapy of Morquio A disease","volume":"47","author":"Mosquera","year":"2012","journal-title":"Process Biochem."},{"key":"10.1016\/j.heliyon.2024.e32555_bib37","series-title":"Short Protocols in Molecular Biology: A Compendium of Methods from Current Protocols in Molecular Biology","author":"Ausubel","year":"1999"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32555_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0009-8981(90)90339-T","article-title":"A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A)","volume":"187","author":"van Diggelen","year":"1990","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32555_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2007.01.004","article-title":"Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase","volume":"91","author":"Tomatsu","year":"2007","journal-title":"Mol. Genet. Metabol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e32555_bib40","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32555_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-016-9981-6","article-title":"Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry","volume":"40","author":"Kubaski","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32555_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2016.12.010","article-title":"Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses","volume":"120","author":"Kubaski","year":"2017","journal-title":"Mol. Genet. Metabol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32555_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1073\/pnas.1111232108","article-title":"Structure-based design of conformation- and sequence-specific antibodies against amyloid beta","volume":"109","author":"Perchiacca","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32555_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012194","article-title":"Enzyme replacement in a human model of mucopolysaccharidosis IVA In-vitro and its biodistribution in the cartilage of wild type mice","volume":"5","author":"Dvorak-Ewell","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32555_bib45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cbpa.2008.06.018","article-title":"Sulfotransferases, sulfatases and formylglycine-generating enzymes: a sulfation fascination","volume":"12","author":"Bojarova","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e32555_bib46","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1111\/j.1742-4658.2010.07769.x","article-title":"Adeno-associated virus gene transfer on Morquio A: effect of promoters and sulfatase-modifying Factor 1","volume":"277","author":"Alm\u00e9ciga-D\u00edaz","year":"2010","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32555_bib47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/BJ20061783","article-title":"SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies","volume":"403","author":"Fraldi","year":"2007","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32555_bib48","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/ddm353","article-title":"Enzyme replacement therapy in a murine model of Morquio A syndrome","volume":"17","author":"Tomatsu","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32555_bib49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/dmd.111.042903","article-title":"Brain-penetrating IgG-iduronate 2-sulfatase fusion protein for the mouse","volume":"40","author":"Zhou","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.heliyon.2024.e32555_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gene.2017.08.043","article-title":"Anaerobic sulfatase maturase AslB from Escherichia coli activates human recombinant iduronate-2-sulfate sulfatase (IDS) and N-acetylgalactosamine-6-sulfate sulfatase (GALNS)","volume":"634","author":"Almeciga-Diaz","year":"2017","journal-title":"Gene"},{"issue":"172","key":"10.1016\/j.heliyon.2024.e32555_bib51","first-page":"1","article-title":"Recombinant protein expression in Escherichia coli: advances and challenges","volume":"5","author":"Rosano","year":"2014","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32555_bib52","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1128\/JB.185.6.2017-2021.2003","article-title":"Definition of the Escherichia coli MC4100 genome by use of a DNA array","volume":"185","author":"Peters","year":"2003","journal-title":"J. Bacteriol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32555_bib53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jbiotec.2004.08.004","article-title":"Advanced genetic strategies for recombinant protein expression in Escherichia coli","volume":"115","author":"Sorensen","year":"2005","journal-title":"J. Biotechnol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e32555_bib54","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/nbt1029","article-title":"Recombinant protein folding and misfolding in Escherichia coli","volume":"22","author":"Baneyx","year":"2004","journal-title":"Nat. Biotechnol."},{"issue":"Pt 2","key":"10.1016\/j.heliyon.2024.e32555_bib55","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1042\/bj2790515","article-title":"Human liver N-acetylgalactosamine 6-sulphatase. Purification and characterization","volume":"279","author":"Bielicki","year":"1991","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32555_bib56","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/oxfordjournals.jbchem.a123697","article-title":"N-acetylgalactosamine-6-sulfate sulfatase in human placenta: purification and characteristics","volume":"110","author":"Masue","year":"1991","journal-title":"J. Biochem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32555_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2007.01.004","article-title":"Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase","volume":"91","author":"Tomatsu","year":"2007","journal-title":"Mol. Genet. Metabol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e32555_bib58","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.1007\/s11033-014-3383-3","article-title":"Computational analysis of human N-acetylgalactosamine-6-sulfate sulfatase enzyme: an update in genotype-phenotype correlation for Morquio A","volume":"41","author":"Olarte-Avellaneda","year":"2014","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32555_bib59","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jmb.2012.08.020","article-title":"The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A","volume":"423","author":"Rivera-Colon","year":"2012","journal-title":"J. Mol. Biol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e32555_bib60","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/sj.emboj.7601087","article-title":"Definition of the bacterial N-glycosylation site consensus sequence","volume":"25","author":"Kowarik","year":"2006","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32555_bib61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/bj1810037","article-title":"Purification and properties of N-acetylgalactosamine 6-sulphate sulphatase from human placenta","volume":"181","author":"Glossl","year":"1979","journal-title":"Biochem. J."},{"issue":"5512","key":"10.1016\/j.heliyon.2024.e32555_bib62","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1126\/science.291.5512.2364","article-title":"Intracellular functions of N-linked glycans","volume":"291","author":"Helenius","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32555_bib63","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jps.21504","article-title":"Effects of glycosylation on the stability of protein pharmaceuticals","volume":"98","author":"Sola","year":"2009","journal-title":"J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32555_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/pd.1970100204","article-title":"Prenatal diagnosis of Morquio disease type A using a simple fluorometric enzyme assay","volume":"10","author":"Zhao","year":"1990","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.heliyon.2024.e32555_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jbiotec.2017.03.033","article-title":"Production of recombinant human acid alpha-glucosidase with high-mannose glycans in gnt1 rice for the treatment of Pompe disease","volume":"249","author":"Jung","year":"2017","journal-title":"J. Biotechnol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32555_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2014.02.011","article-title":"Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology","volume":"112","author":"Grabowski","year":"2014","journal-title":"Mol. Genet. Metabol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32555_bib67","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10545-015-9886-9","article-title":"Mannose receptor-mediated delivery of moss-made alpha-galactosidase A efficiently corrects enzyme deficiency in Fabry mice","volume":"39","author":"Shen","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e32555_bib68","doi-asserted-by":"crossref","first-page":"7935","DOI":"10.1074\/jbc.M113.512780","article-title":"Complex determinants in specific members of the mannose receptor family govern collagen endocytosis","volume":"289","author":"Jurgensen","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32555_bib69","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/glycob\/cwf096","article-title":"Production in yeast of alpha-galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease","volume":"12","author":"Chiba","year":"2002","journal-title":"Glycobiology"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32555_bib70","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1467-7652.2007.00263.x","article-title":"Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system","volume":"5","author":"Shaaltiel","year":"2007","journal-title":"Plant Biotechnol. J."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e32555_bib71","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.str.2015.09.004","article-title":"Insights into collagen uptake by C-type mannose receptors from the crystal structure of Endo180 domains 1-4","volume":"23","author":"Paracuellos","year":"2015","journal-title":"Structure"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e32555_bib72","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1074\/jbc.M513277200","article-title":"Structural model for the mannose receptor family uncovered by electron microscopy of Endo180 and the mannose receptor","volume":"281","author":"Boskovic","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e32555_bib73","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s00018-007-7497-9","article-title":"Extended and bent conformations of the mannose receptor family","volume":"65","author":"Llorca","year":"2008","journal-title":"Cell. Mol. Life Sci. : CM"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e32555_bib74","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/tra.12284","article-title":"Lrp1\/LDL receptor play critical roles in mannose 6-phosphate-independent lysosomal enzyme targeting","volume":"16","author":"Markmann","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.heliyon.2024.e32555_bib75","first-page":"1","article-title":"Di-sulfated keratan sulfate as a novel biomarker for mucopolysaccharidosis II, IVA, and IVB","volume":"21","author":"Shimada","year":"2015","journal-title":"JIMD Rep"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e32555_bib76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymgme.2016.11.007","article-title":"Mucopolysaccharidosis IVA and glycosaminoglycans","volume":"120","author":"Khan","year":"2017","journal-title":"Mol. Genet. Metabol."},{"issue":"24","key":"10.1016\/j.heliyon.2024.e32555_bib77","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/hmg\/ddg366","article-title":"Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-\/-) produced by targeted disruption of the gene defective in Morquio A disease","volume":"12","author":"Tomatsu","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2024.e32555_bib78","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1093\/hmg\/ddi364","article-title":"Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase","volume":"14","author":"Tomatsu","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32555_bib79","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ymgme.2007.02.009","article-title":"Murine model (Galns(tm(C76S)slu)) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins","volume":"91","author":"Tomatsu","year":"2007","journal-title":"Mol. Genet. Metabol."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e32555_bib80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ymgme.2016.09.005","article-title":"Glycosaminoglycans detection methods: applications of mass spectrometry","volume":"120","author":"Kubaski","year":"2017","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.heliyon.2024.e32555_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.38326","article-title":"Drug discovery and development for rare genetic disorders","author":"Sun","year":"2017","journal-title":"Am. J. Med. Genet."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024085864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024085864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:00:00Z","timestamp":1790542800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024085864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":81,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405844024085864"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32555","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in a glyco-engineered Escherichia coli strain","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e32555"}}